Psoriasis

COVID-19-associated hospitalization was more common in patients who were taking oral methotrexate but not in those taking biologics, according to a study.

Psoriasis news in the first half of 2021 has included updates regarding the COVID-19 vaccine and research regarding treatment options.

Patients with psoriasis or psoriatic arthritis treated with ustekinumab demonstrated a 1.4- to 3-times lower risk for hospitalization with serious infections than those who received other biologics or apremilast, according to data.

As COVID-19 prevented millions of patients from seeing their doctors, the demand for telemedicine in dermatology increased.

In this video, April Armstrong, MD, MPH, of the Keck School of Medicine at the University of Southern California, Los Angeles, discussed improvements seen in secondary efficacy endpoints with topical tapinarof, an aryl hydrocarbon receptor modulating agent that is in late phase development, that were presented at AAD VMX 2021.

In this video, April Armstrong, MD, MPH, of the Keck School of Medicine at the University of Southern California, Los Angeles, spoke with Healio about findings from a study presented at AAD VMX 2021 that evaluated the use of topical roflumilast in patients with psoriasis.

Switching to bimekizumab resulted in better outcomes among certain patients with psoriasis who did not respond as well to adalimumab, according to results presented at AAD VMX 2021.

New data presented at AAD VMX 2021 suggest that certain clinical and demographic factors may affect patient perceived remission of psoriasis.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about COVID-19 treatment options available to patients with psoriasis.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, spoke with Healio about COVID-19 vaccination among patients with psoriasis.